News

New on the NCP Flanders website: Call Topic Heatmap

Published on
| 3 months ago
Programmes
  • Horizon Europe
  • Digital Europe

Keeping track of the exact timelines of multiple Horizon Europe and/or Digital Europe calls can be challenging, especially for organisations active in several domains at once. To help you plan ahead, NCP Flanders has developed a new downloadable Call Topic Heatmap.

This new Excel-based tool provides a visual overview of when call topics are open across the different subdomains of Horizon Europe and in Digital Europe, helping organisations identify and anticipate peak periods.

Each row in the heatmap represents a specific programme or subdomain, while the timeline is organised by week. As new calls open, the number of available topics increases and the colour intensity changes accordingly. The darker the colour, the higher the number of open topics at that moment in time.

You can download the call topic heatmap here on the Call Topic Overview Page, available under Tools.

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2049 articles available Browse all news
  • EIC

EIC Work Programme 2027 adopted

The 2027 work programme opens funding opportunities worth over €1.8 billion for strategic technologies and scaling up companies. The EIC work programme 2027 details the funding in six main schemes: EIC Pathfinder EIC Transition Advanced Innovation Challenges EIC Accelerator The EIC Strategic Technologies for Europe Platform (STEP) Scale Up EIC...

Read more
  • Defence
  • DIRS

Start2Def 2026 call open

The Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.